You don't take life for granted: Rajdeep Sardesai on his prostate cancer battle
Veteran Indian journalist Rajdeep Sardesai disclosed his recent battle with prostate cancer during a panel discussion at the India Today Health Wealth Conclave 2026. He described how a routine medical checkup prior to a scheduled hernia procedure led to the discovery of elevated PSA levels, resulting in a diagnosis of early-stage but high-grade prostate cancer. Sardesai recounted canceling planned travel to watch cricket matches in London after receiving the news in June of the previous year. In a joint session with his treating physician, Dr. Anshuman Agarwal, Sardesai detailed his decision-making process, noting that he ultimately chose surgical intervention over radiation therapy after seeking independent medical opinions. The article highlights the role of family support, specifically from his son who is also a doctor, in helping Sardesai manage the emotional impact of the diagnosis. Currently in remission, Sardesai now attends regular follow-up appointments every six months, while Dr. Agarwal used the platform to urge men to prioritize proactive screening based on age and family history.
A PSA level of 28.9 ng/mL indicates a significantly elevated risk of prostate cancer, yet it does not serve as a definitive diagnostic confirmation. Medical experts emphasize that while such a high reading warrants immediate investigation, it reflects general prostate abnormality rather than specific malignancy. Prostate-specific antigen, produced by prostate cells, circulates in the blood and often rises with age. Various non-cancerous conditions, including inflammation, infection, and benign enlargement, can similarly elevate these markers. Consequently, clinicians view a value exceeding 10 ng/mL as associated with a substantially higher likelihood of cancer, and levels above 20 ng/mL as a high-risk feature if malignancy is later confirmed. However, the number alone cannot distinguish between benign issues and cancer. Doctors assess the patient’s age, symptoms, physical examination results, historical PSA trends, and additional tests before drawing conclusions. Infection or inflammation may cause substantial, temporary spikes, necessitating treatment of the underlying condition followed by a repeat test to observe if levels decline. If suspicion persists, a multiparametric MRI helps identify suspicious areas, guiding a targeted biopsy. Only a biopsy, which examines tissue under a microscope, provides a definitive diagnosis. In a separate but related development regarding the disease, veteran journalist Rajdeep Sardesai disclosed his personal battle with prostate cancer at the India Today Health Wealth Conclave 2026 in New Delhi. Speaking on October 30, 2026, during a session titled "Humne Cancer Ko Haraya," Sardesai detailed how a routine checkup altered his life trajectory. He had originally purchased tickets to watch India play England at Lord's Cricket Ground in London. Instead, a phone call in June of the previous year informed him of his diagnosis. Sardesai noted that he did not initially seek a cancer screening. He was undergoing preparation for a hernia operation when routine tests revealed a dropping blood count and elevated PSA levels. Subsequent investigations, including an MRI and a targeted fusion biopsy, confirmed the presence of high-grade prostate cancer, although it was detected at an early stage. Sardesai described his initial reaction to the news as one of shock, asking, "Why me?" He recounted how his plans for a foreign trip were replaced by urgent decisions regarding surgical options. His treating physician, Dr. Anshuman Agarwal, a Senior Urologist at Indraprastha Apollo Hospital, joined him on stage to discuss the case. Dr. Agarwal explained that he presented Sardesai with two primary treatment paths: surgery or radiation therapy. The doctor encouraged Sardesai to seek independent medical opinions before making a final decision. Sardesai ultimately chose surgery. He credited his son, who is also a medical professional, with helping him process the emotional impact of the diagnosis. His son’s reassurance allowed Sardesai to shift focus from self-pity to active management of the illness. The recovery period included challenging moments. Sardesai remained hospitalized for five days, keeping his mind occupied by watching comedy films, following cricket matches, and listening to music by Kishore Kumar. He is currently in remission. His follow-up schedule has transitioned from monthly appointments to checks every six months. Dr. Agarwal used the platform to warn that prostate cancer can progress without obvious symptoms. Urinary difficulties are frequently misinterpreted as standard aging processes, leading to delayed diagnoses. Some patients experience no symptoms whatsoever. The doctor advised that men with a family history of prostate issues, particularly among first-degree relatives, should begin discussions about screening in their late 40s or early 50s. For men without such a history, consideration of screening around age 55 is recommended. Sardesai urged the public to destigmatize cancer diagnoses and improve access to screening services in India. He stated that individuals should not hide their conditions. Reflecting on his experience, Sardesai said he no longer takes life for granted. He expressed a desire to travel more and reduce anxiety about future uncertainties. He acknowledged the critical support of his wife, children, friends, and assistant during his treatment. His central message focused on valuing the people present during vulnerable times. He described life as a journey containing both highs and lows, emphasizing the importance of enjoying the positive aspects while coping with the negative ones. The conclave highlighted the intersection of personal narrative and medical guidance in addressing prevalent health concerns.
The article addresses a common medical concern regarding a Prostate-Specific Antagonist (PSA) blood test result of 28.9 ng/mL, clarifying that while this level is significantly elevated, it does not definitively confirm prostate cancer. Experts consulted, including Dr. Kapil Jain and Dr. Vishnu Hari, explain that PSA is a non-specific marker for prostate abnormalities, meaning levels can be raised by various factors such as age, inflammation, infections, or benign prostatic hyperplasia. Although a PSA level above 10 ng/mL indicates a substantially higher likelihood of cancer, and levels above 20 ng/mL are considered high-risk features if cancer is present, the value alone is insufficient for diagnosis. Physicians emphasize the necessity of comprehensive evaluation, including patient history, physical examinations, and additional diagnostic tests like biopsies, to determine the underlying cause of the elevation.
Bias read (Center): The article covers a medical inquiry and provides expert opinions on interpreting lab results. There are no political actors, policies, or ideological debates involved. The tone is purely informational and clinical, making any political lean irrelevant.
Why factuality (95): The medical facts presented align with standard urological guidelines. The distinction between PSA as a marker of abnormality versus a specific diagnostic tool is accurate. The thresholds cited (>10 ng/mL for increased likelihood, >20 ng/mL for high risk) are consistent with general medical consensu
Why objectivity (95): The tone is informative and neutral. It addresses a common patient anxiety without using alarmist language. The inclusion of a disclaimer regarding professional consultation enhances the responsible nature of the piece. There is no evident bias or editorializing.
Veteran Indian journalist Rajdeep Sardesai disclosed his recent battle with prostate cancer during a panel discussion at the India Today Health Wealth Conclave 2026. He described how a routine medical checkup prior to a scheduled hernia procedure led to the discovery of elevated PSA levels, resulting in a diagnosis of early-stage but high-grade prostate cancer. Sardesai recounted canceling planned travel to watch cricket matches in London after receiving the news in June of the previous year. In a joint session with his treating physician, Dr. Anshuman Agarwal, Sardesai detailed his decision-making process, noting that he ultimately chose surgical intervention over radiation therapy after seeking independent medical opinions. The article highlights the role of family support, specifically from his son who is also a doctor, in helping Sardesai manage the emotional impact of the diagnosis. Currently in remission, Sardesai now attends regular follow-up appointments every six months, while Dr. Agarwal used the platform to urge men to prioritize proactive screening based on age and family history.
Bias read (Center): The article focuses exclusively on personal health experiences and medical advice, using neutral, factual language without political commentary or partisan framing.
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
★
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.